AstraZeneca India unit hits over 3-month high after British vaccine approval (updated)

Wockhardt

30/12/2020 09:07

(Adds Wockhardt share movement, context, updates trading volume
for Astrazeneca Pharma India)
    ** Shares of AstraZeneca Plc's  AZN.L  Indian arm  ASTR.NS 
jump as much as 5.1% to 4,772 rupees; their highest level since
Sept. 8
    ** Britain on Wednesday became the first country in the
world to approve AstraZeneca and Oxford University's COVID-19
vaccine  urn:newsml:reuters.com:*:nL8N2JA0KE
    ** Serum Institute of India, the local manufacturer of
AstraZeneca's vaccine, said on Monday that approval from India's
drug regulator would likely follow British approval  urn:newsml:reuters.com:*:nL1N2J80HJ
    ** Shares of Indian drugmaker Wockhardt Ltd  WCKH.NS  also
up as much as 8.5% to 553 rupees - their highest since Nov. 21,
2018
    ** WCKH has a deal with the UK to supply millions of doses
of multiple COVID-19 vaccines, including AstraZeneca's
 urn:newsml:reuters.com:*:nL4N2F52FV 
    ** India accounts for the world's second-highest coronavirus
infections at about 10.24 mln, though cases have declined since
September peak 
    ** More than 550,000 ASTR shares traded, 8.1x 30-day moving
avg
    ** Up to Tuesday's close, stock had risen 73.5% YTD


 (Reporting by Anuron Kumar Mitra in Bengaluru)
 ((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))